Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster
文献类型:期刊论文
作者 | Zhang, Ya-Nan3,4; Zhang, Hong-Qing1,4; Wang, Gui-Feng5; Zhang, Zhe-Rui4; Li, Jia-Qi1,4; Chen, Xiao-Ling1,4; Hu, Yan-Yan1,4; Zeng, Xiang-Yue1,4; Shi, Yu-Jia2; Wang, Jing1,4 |
刊名 | ANTIVIRAL RESEARCH |
出版日期 | 2023 |
卷号 | 209页码:9 |
ISSN号 | 0166-3542 |
关键词 | Omicron VEEV VRP Replicable mRNA |
DOI | 10.1016/j.antiviral.2022.105507 |
通讯作者 | Wang, Chun-He(wangc@simm.ac.cn) ; Zhu, Bing(zhubing@gzhmu.edu.cn) ; Zhang, Bo(zhangbo@wh.iov.cn) |
英文摘要 | The Omicron variant is sweeping the world, which displays striking immune escape potential through mutations at key antigenic sites on the spike protein, making broad-spectrum SARS-CoV-2 prevention or therapeutical strategies urgently needed. Previously, we have reported a hACE2-targeting neutralizing antibody 3E8, which could efficiently block both prototype SARS-CoV-2 and Delta variant infections in prophylactic mouse models, having the potential of broad-spectrum to prevent SARS-CoV-2. However, preparation of monoclonal neutral-izing antibodies is severely limited by the time-consuming process and the relative high cost. Here, we utilized a modified VEEV replicon with two subgenomic (sg) promoters engineered to express the light and heavy chains of the 3E8 mAb. The feasibility and protective efficacy of replicating mRNA encoding 3E8 against Omicron infection in the hamster were demonstrated through the lung targeting delivery with the help of VEEV-VRP. Overall, we developed a safe and cost-effective platform of broad-spectrum to prevent SARS-CoV-2 infection. |
WOS关键词 | VARIANT |
资助项目 | National Natural Science Foundation of China ; China Postdoctoral Science Foundation ; [32200132] ; [2022M720895] |
WOS研究方向 | Pharmacology & Pharmacy ; Virology |
语种 | 英语 |
出版者 | ELSEVIER |
WOS记录号 | WOS:000910681600001 |
源URL | [http://119.78.100.183/handle/2S10ELR8/303884] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Wang, Chun-He; Zhu, Bing; Zhang, Bo |
作者单位 | 1.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 2.Hunan Normal Univ, Sch Med, Changsha 410081, Peoples R China 3.Guangzhou Med Univ, Inst Pediat, Ctr Lab, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Peoples R China 4.Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China 5.Shanghai Inst Mat Med, Biotherapeut Discovery Res Ctr, Shanghai, Peoples R China |
推荐引用方式 GB/T 7714 | Zhang, Ya-Nan,Zhang, Hong-Qing,Wang, Gui-Feng,et al. Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster[J]. ANTIVIRAL RESEARCH,2023,209:9. |
APA | Zhang, Ya-Nan.,Zhang, Hong-Qing.,Wang, Gui-Feng.,Zhang, Zhe-Rui.,Li, Jia-Qi.,...&Zhang, Bo.(2023).Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster.ANTIVIRAL RESEARCH,209,9. |
MLA | Zhang, Ya-Nan,et al."Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster".ANTIVIRAL RESEARCH 209(2023):9. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。